Advertisement

Can Good CARMA Prevent Abdominal Aortic Aneurysm?

Published:April 20, 2023DOI:https://doi.org/10.1016/j.cjca.2023.04.012
      Aortic aneurysm is a focal and permanent dilation of the aorta and, if left untreated, can expand progressively and increase the risk of aortic rupture and death. At present, there is no effective pharmacologic treatment for aortic aneurysm; corrective surgery is the only viable treatment. Therefore, a better understanding of the mechanism underlying aortic aneurysm is required to identify potential treatments. In this issue of the Canadian Journal of Cardiology, Yao et al.
      • Yao Y.
      • Cao Y.
      • Xu Y.
      • et al.
      CARMA3 deficiency aggravates angiotensin II-induced abdominal aortic aneurysm development interacting between endoplasmic reticulum and mitochondria.
      report that whole body genetic loss of caspase recruitment domain and membrane-associated guanylate kinase-like domain protein 3 (CARMA3) increases the risk of abdominal aortic aneurysm (AAA) formation and aortic rupture in angiotensin II (Ang II)-infused mice. Aortic dilation is caused by weakened aortic wall brought about by adverse remodelling of the aortic structure.
      • Jana S.
      • Hu M.
      • Shen M.
      • Kassiri Z.
      Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm.
      Vascular smooth muscle cells (VSMCs) are critical cell types in the tunica media of the aortic wall and are responsible for production of extracellular matrix (ECM) proteins as well the contractile function that enforces the recoil of the aortic wall during cardiac diastole.
      • Liu B.
      • Granville D.J.
      • Golledge J.
      • Kassiri Z.
      Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.
      Therefore, impaired function or loss of VSMCs can deteriorate the strength and integrity of the aortic wall and cause aortic dilation and aneurysm. There are several types of cell death that can be inflicted on the VSMCs, including necrosis, apoptosis, pyroptosis, autophagy, and ferroptosis. In recent years, pyroptosis, a proinflammatory programmed cell death that is distinct from apoptosis—a noninflammatory programmed cell death—has been receiving more attention in cardiovascular diseases.
      • Cookson B.T.
      • Brennan M.A.
      Pro-inflammatory programmed cell death.
      Pyroptosis is triggered by the activation of the NOD-like receptor 3 (NLRP3) inflammasome and inflammatory caspases. Caspase I can cleave gasdermin D (GSDMD) into N-terminal (GSDMD-N) and C-terminal domains. GSDMD-N then oligomerizes to form pores in the cell membrane, allowing mature interleukin (IL)-1β and IL-18 to be released into the extracellular space. Meanwhile, water entering through the pores causes cell swelling and lysis, eventually resulting in cell-membrane rupture.
      • Yu P.
      • Zhang X.
      • Liu N.
      • Tang L.
      • Peng C.
      • Chen X.
      Pyroptosis: mechanisms and diseases.
      Inflammation is a major contributor to formation of AAA, and the contribution of inflammasomes to this process has received more attention in recent years.
      • Wortmann M.
      • Klotz R.
      • Kalkum E.
      • Dihlmann S.
      • Bockler D.
      • Peters A.S.
      Inflammasome targeted therapy as novel treatment option for aortic aneurysms and dissections: a systematic review of the preclinical evidence.
      Activation of the NLRP3-caspase-1 system in human and mouse aneurysmal tissue results in the degradation of the contractile proteins in VSMCs and can promote formation of aneurysms.
      • Wu D.
      • Ren P.
      • Zheng Y.
      • et al.
      NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome degrades contractile proteins: implications for aortic biomechanical dysfunction and aneurysm and dissection formation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yao Y.
        • Cao Y.
        • Xu Y.
        • et al.
        CARMA3 deficiency aggravates angiotensin II-induced abdominal aortic aneurysm development interacting between endoplasmic reticulum and mitochondria.
        Can J Cardiol. 2023; xxx:xxx-xx
        • Jana S.
        • Hu M.
        • Shen M.
        • Kassiri Z.
        Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm.
        Exp Mol Med. 2019; 51: 1-15
        • Liu B.
        • Granville D.J.
        • Golledge J.
        • Kassiri Z.
        Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.
        Am J Physiol Heart Circ Physiol. 2020; 318: H652-H670
        • Cookson B.T.
        • Brennan M.A.
        Pro-inflammatory programmed cell death.
        Trends Microbiol. 2001; 9: 113-114
        • Yu P.
        • Zhang X.
        • Liu N.
        • Tang L.
        • Peng C.
        • Chen X.
        Pyroptosis: mechanisms and diseases.
        Signal Transduct Target Ther. 2021; 6: 128
        • Wortmann M.
        • Klotz R.
        • Kalkum E.
        • Dihlmann S.
        • Bockler D.
        • Peters A.S.
        Inflammasome targeted therapy as novel treatment option for aortic aneurysms and dissections: a systematic review of the preclinical evidence.
        Front Cardiovasc Med. 2021; 8805150
        • Wu D.
        • Ren P.
        • Zheng Y.
        • et al.
        NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome degrades contractile proteins: implications for aortic biomechanical dysfunction and aneurysm and dissection formation.
        Arterioscler Thromb Vasc Biol. 2017; 37: 694-706
        • Navas-Madronal M.
        • Rodriguez C.
        • Kassan M.
        • et al.
        Enhanced endoplasmic reticulum and mitochondrial stress in abdominal aortic aneurysm.
        Clin Sci (Lond). 2019; 133: 1421-1438
        • Zhang S.
        • Lin X.
        CARMA3: Scaffold protein involved in NF-kappaB signaling.
        Front Immunol. 2019; 10: 176
        • McAllister-Lucas L.M.
        • Ruland J.
        • Siu K.
        • et al.
        CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
        Proc Natl Acad Sci U S A. 2007; 104: 139-144
        • Liu T.
        • Zhang L.
        • Joo D.
        • Sun S.C.
        NF-kappaB signaling in inflammation.
        Signal Transduct Target Ther. 2017; 217023
        • Saha R.N.
        • Jana M.
        • Pahan K.
        MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65.
        J Immunol. 2007; 179: 7101-7109
        • Gao J.
        • Cao H.
        • Hu G.
        • et al.
        The mechanism and therapy of aortic aneurysms.
        Signal Transduct Target Ther. 2023; 8: 55
        • Basu R.
        • Fan D.
        • Kandalam V.
        • et al.
        Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin II.
        J Biol Chem. 2012; 287: 44083-44096
        • Jana S.
        • Chute M.
        • Hu M.
        • et al.
        ADAM (a disintegrin and metalloproteinase) 15 deficiency exacerbates Ang II (angiotensin II)-induced aortic remodeling leading to abdominal aortic aneurysm.
        Arterioscler Thromb Vasc Biol. 2020; 40: 1918-1934
        • Daugherty A.
        • Manning M.W.
        • Cassis L.A.
        Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.
        J Clin Invest. 2000; 105: 1605-1612
        • Shen M.
        • Hu M.
        • Fedak P.W.M.
        • Oudit G.Y.
        • Kassiri Z.
        Cell-specific functions of ADAM17 regulate the progression of thoracic aortic aneurysm.
        Circ Res. 2018; 123: 372-388
        • Kilic T.
        • Okuno K.
        • Eguchi S.
        • Kassiri Z.
        Disintegrin and metalloproteinases (ADAMs [a disintegrin and metalloproteinase] and ADAMTSs [ADAMs with a thrombospondin motif]) in aortic aneurysm.
        Hypertension. 2022; 79: 1327-1338

      Linked Article